A microcap company getting to put its name alongside a blue chip is generally beneficial for the upstart. That’s the case for decontamination and infection prevention specialist TOMI Environmental Solutions (OTCQX: TOMZ) on Wednesday as shareholders respond positively to further credence being lent to its disinfection and decontamination offerings.
TOMI said that is has completed installation of its iHP® custom built-in system at the newly constructed research and development facility of Pfizer (NYSE: PFE) in Chesterfield, Missouri. The biopharmaceutical stalwart broke ground on the 295,000 square foot facility in June 2017. The facility is home to Pfizer’s BioTherapeutics Pharmaceutical Sciences group, which works on R&D of experimental new medicines.
TOMI installed several products from its SteraMist brand, a hydrogen peroxide-based mist and fog underpinned by TOMI’s premier BIT™ (Binary Ionization Technology®) platform, at the Chesterfield facility. Overall, TOMI installed SteraMist systems in four clean room cGMP (current good manufacturing practice) suites and 20 ceiling mounted SteraMist applicators, which are tied in to dual generator control cabinets that can run a single application or all at once as necessary.
Pfizer will use the custom system daily as a means to protect against the potential spread of any pathogens. Pfizer is well attuned to the quality of the TOMI technology, already utilizing it in several of their facilities across the U.S.
Shares of TOMZ popped up to a high of 12.8 cents this morning, marking the highest level for the stock since April 20, 2018. With about 380,000 shares changing hands and only minutes left in the trading day, the stock is posting its best volume day since last April as well. The downside – if it could be called that – is that the stock lost its early-day momentum, trading flat at 12 cents as the closing bell approaches.